HeartSciences (HSCS) Share-based Compensation Growth (1y) (2022 - 2026)
HeartSciences (HSCS) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 12.94% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 59.09% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -30.44% |
| 10 | HeartSciences | 6.20 Mn | 4.50 Mn | - | 238.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 238.57% |
| Oct 31, 2025 | 0.00% |
| Jul 31, 2025 | 219.97% |
| Apr 30, 2025 | 38.27% |
| Jan 31, 2025 | -6.25% |
| Oct 31, 2024 | -6.25% |
| Jul 31, 2024 | -56.23% |
| Jan 31, 2024 | -5.83% |
| Oct 31, 2023 | -5.83% |
| Jul 31, 2023 | -91.69% |
| Jan 31, 2023 | 1,366.78% |
| Oct 31, 2022 | 210,172.28% |
| Jul 31, 2022 | 93,125.61% |